When it comes to cannabis stocks, the public can't get enough. After years of challenging access to capital, 2018 has seen a remarkable improvement for U.S. cannabis operators. In the summer, two leading companies went public, MedMen and Green Thumb Industries. Both stocks have performed well, and each of the companies has subsequently priced secondary offerings, raising additional capital to fund acquisitions and capital expenditures. Aurora Cannabis spin-out Australis Capital soared in its trading initially…
No comments:
Post a Comment